Thursday, April 16, 2009

How long should a post-doctoral fellowship last?

I think that we have a privileged view of this question in Epidemiology. None of the professors who were being hired when I started my PhD had ever done a post-doctoral fellowship (as other than a one year stint to get another university on their CV; only about 50% of them had done even that).

Now I am entering the second year of a post-doctoral fellowship and you can see the change where it is becoming common to do a multi-year fellowship. Although, I still see cases of people being hired into faculty directly out of the PhD or, more commonly, trying to be hired as faculty directly out of their PhD program.

So this makes me sympathetic to this post by MsPhd. It being widely panned elsewhere, but I wonder if the main point is being missed. Post-doctoral training is an ideal phase for "creep" in expectations. It's pretty clear that standards are rising in biomedicine for what it takes to succeed. Some of this is good -- a solid arms race will produce better outcomes. But the dark side of this process is people being kept back for very long periods of time. If this process leads to happy outcomes (or decent outcomes) for all involved than this is perfectly fine.

But what if it doesn't?

What is the ideal length of a fellowship training period? My field's traditional answer of "none" seems too short but more than five years seems too long. Or am I missing something?

Wednesday, April 15, 2009

Tenure Track?

Over in blue lab coats, a comment was made about the downside of only accepting students that looked promising for tenure track positions. Namely, this criteria would bias against students who are unlikely to be accepted into tenure track positions.

Now, this bias can take one of two forms. There can be irrational discrimination (such as age or gender-based). I think that we can all agree that this type of discrimination is a bad thing and should be avoided.

But at a more pragmatic level, the scheme where one student in ten succeeds (and these appear to be optimistic odds) at the primary career path of a 5+ year high intensity training program seems to need revision as well. If the goal of the academy is to produce the next generation of academic researchers then we need to fess up to the unfair nature of over-production.

And don't get me started on the whole "non-tenure track" movement in medical research. Vile!

Tuesday, April 14, 2009

Why clear methods are important

A really nice post was done today by DrugMonkey. I think that he issues that DrugMonkey raises are even more important in epidemiology than in bench science. In bench science you have the possibility of replication in a strict sense (and it is, in fact, a governing principle of bench science). In Epidemiology, the population changes between studies and it is difficult to compare between populations. As Heraclitus said "You can never step into the same river twice"; in Epidemiology you never have the same study population twice.

Perversely, this fact actually makes the methods more important as failure to replicate could also indicate unique features of a population. This makes it critical to be able to separate methodological issues from population issues, insofar as this is possible.

Given how badly medical papers seem to document decisions (part of it being a style issue for the field), there is a lot we could do to improve on matters.

Monday, April 13, 2009

Who will be successful?

Post from Professor in Training and Physio-Prof have gotten me thinking about academic evaluation procedures. The discussion about who got hired and subsequent success makes me consider one of the difficult issues in academic hiring. You want to hire people who will be successful. But, most of the time, you don't know what success will look like. So you use proxy measures; some of which are blindingly unfair. For example, the institution that a person attended could be due to brilliance or it could be due to location, connections or a number of other factors.

The same thing is true of obtaining funding. This issue seems to be the major hurdle for success as a junior academic. I seem to have no trouble with publishing papers but I have had a series of miserable failures when applying for fellowships. I was never sure why success in one domain translated into abject failure in another. Or maybe I just never understood the CIHR criteria to fund students?

But if the measure of success of a fellowship is productivity then it is odd that I never obtained one as many of my peers who were easily offered several choices had far less success at producing research. In this sense, I find the academy more difficult to succeed in than my old career as as statistician. Back then, poor prognostic signs could be overcome with hard work, smart ideas and a lot of success. People stopped caring what your alma mater was once you become highly success.

In academics, failing to get a fellowship is a reason not to promote somebody further. So once you have one thing go wrong it is much harder to get back into the pipeline. These days I have half given up on a career path and mostly stick around doing cool research. I like what I do and that is rare enough that I have kind of stopped caring about the whole "career management" issues.

But it strikes me as a sub-optimal system in a lot of ways . . .

Saturday, April 11, 2009

OT: Knights of the Old Republic

While I know I am late to the table in singing the praises of this game, the storyline is remarkable. It is a very nice implementation of an interactive story and seems to strike a good balance between the level of restriction required to make voice acting viable and freedom to do interesting things. It is a good plot with a rather well foreshadowed plot twist.

But why, for what possible reason, would they insert a "difficult to beat" (for my bad reflexes at least) first person shooter with a long sequence of videos between the last save point and the shooter. I think I have seen the same 5 minutes of video so many times that I want to scream!

Otherwise a fine game!

Thursday, April 9, 2009

Bayesian Model Averaging

I know that it is the best choice for selecting variables for predictive models. I know that it is massively superior to stepwise model selection. Chris Volinsky's page is a great resource for doing these models in R.

But I don't speak R and I have been resisting for a while. It's the decade of SAS training -- I am so fast in SAS that it feels like I am walking through water when I switch to R or STATA. I can do it but the experience is unpleasant, to say the least.

On the other hand, it's the right approach for a project that I am looking at right now. So maybe it is time to bite the bullet and use a new software interface?

Tuesday, April 7, 2009

When non-linear relationships attack

In a lot of cases, in epidemiology, it is conventional to assume that relationships are linear. In a lot of cases this assumption seems to be pretty reasonable. Occasionally you get a relationship where very large values have biological plausibility (like income or albumin excretion rate) and a base 2 logarithmic transformation is a more logical way to proceed.

So far, so good.

Now look at the rate of rate of change of bone mineral density by age for women as reported in this article from the Canadian Medical Association Journal. Between ages 25 and 40 the rate of change of bone mineral density is positive. Then, between ages 40 and 60 the rate of change is negative. Suddenly, at age 60+, the rate of change becomes positive again. Yes, the first derivative of the relationship between age and bone mineral density is quadratic! That would rather imply that the actual relationship is cubic!!

Without seeing this sort of high quality descriptive data, I would have screamed "overfit" if I saw a cubic age term in a statistical model. As it is, I am having pessimistic thoughts about just have big the sample size needs to be in order to estimate the polynomial association between age and bone mineral density.

Now imagine that you are trying to remove confounding by age from another association; just how are you going to be sure that you don't have residual confounding?

Wow, juSt wow!

Monday, April 6, 2009

Stepwise Regression

Why is it so hard to get consensus on a good variable selection technique for exploratory models? The classic one, implemented everywhere and understood by everyone, is really sub-optimal (Stepwise regression -- I am looking at you). It seems to just love to include noise parameters which make any and all models difficult to explain.

Sure, you can build a model based on theory but what do you do when you want to know what factors might be associated with an outcome? And, of course, exploratory datasets tend to be the smallest possible data sets!!

Grrrr . . . .

Friday, April 3, 2009

Reporting results

Writing an effective scientific paper is an art form. It requires presenting a complex idea with about 3000 words. However, it is always the case that there are features of the study that are hard to describe cleanly with a small number of words. So what does one do?

If you go into detail then you inevitably confuse the reader. On the other hand, you want to produce the most complete report possible. Online supplements can help but only so far.

This happened to me in this paper:

Delaney JAC, Daskalopoulou SS, Suissa S. Traditional versus marginal structural models to estimate the effectiveness of β-blocker use on mortality after myocardial infarction. Pharmacoepidemiol Drug Saf 2009; 18(1):1-6.

There were two effects going on in the same paper. One, we were accounting for time dependent confounding. Two, we were switching from a conditional to a marginal estimate. Both of these changes contribute to the differences in estimates.

But does separating them increase or decrease confusion? If the goal is to find an analytic approach that is equivalent to a randomized controlled trial then the reasons why are less important.

My question is whether I'd aid understanding by pointing these subtle points out or if I would enhance confusion by bringing in tangential points. To this day I question which approach was correct!

Thursday, April 2, 2009

Budget Cuts

One of the hardest things to handle in the modern environment is that the academy is not designed for dynamism. It is based on a system where hard work and apprenticeship eventually lead to a slow succession of improvements. However, when circumstances can change rapidly this puts the whole system into flux. Positions and outcomes that people have labored for decades to achieve can now be at risk.

I think that this situation is less true for the very senior people and more for those "too far in to back out" but who have not "really made it yet". Basically, PhD Students, post-doctoral fellows and assistant professors are the class at risk and are often placed into situation that are Kafkaesque.

Now it is hard to argue for who deserves resources; "deserve" being such a complicated word. But it is pretty clear to me that the budget cuts to higher education (at least here in the state of Washington) look to be pretty deep. I suspect few companies would cut so deeply unless they were in crisis.

This leads me to ask: is higher education failing so badly that it should count as being in crisis?

But, either way, there really is not a lot of fat, per se, left to be cut. Schools seems to be in (generally) slightly poor repair. Equipment seems to old and a lot of work-arounds exist. Teaching resources are hardly in surplus. It could be that we are trying to do too much with too little. But that suggests rethinking of priorities -- not the brutal selection of massive reductions in budgets.

Or at least that is the way that I see it.

Wednesday, April 1, 2009

What to do in hard times

In this time of funding cuts and stress, what is the right reaction? I think that Professor in Training nails it: keep working! Stressing about what might happen is useful only insofar as it informs contingency planning. But, as a post-doctoral fellow, I have limited options that don't involve trying to develop a record of accomplishment.

One day I might get around to telling the long story of my attempts to move forward into the academy. But, for the moment, let me say that I like this attitude. Way better than assuming that disaster is coming and seeing that as an excuse for there to be at least some excitement in life. I really hope that I never get that cynical.

I like research but I admit that I also really liked working in the private sector. It had it's downsides, but I liked the dynamism and the idea that accomplishment was to be prized. I think that is why I have liked my current unit so much -- they have the same sort of culture!

Tuesday, March 31, 2009

OT: Dentists

I know that sometimes you need to inflict pain to make things better in the long run. And I am a happier person with the idea that I will have some sort of teeth in middle age.

But it is not pleasant to have three hours of solid dental drilling!!

:-(

Monday, March 30, 2009

More on Tenure

There is an interesting discussion on DrugMonkey about Tenure.

I think that the original comments are making a rather important point. High value research with a short term pay-off is ideally suited to the private sector. They have every advantage in pursuing these goals and lack the "overhead" of an academic institution. I know that discussions of comparative advantage can be complicated but this situation is one where the private sectors really are better poised to solve the questions.

The advantage of the academy is in long term planning and results. This environment gives stability and the ability to pursue dead ends. Even if the academy was better at some short term goals, it's still better to have it focus on the goals where the structure is advantaged relative to the private sector.

One argument against tenure involves the complicated issue of mandatory retirement. I think that this issue is not unique to academia and it is an independent issue from tenure. It is also unclear, in a world where pensions are so unstable, what the options are. Perhaps we need to reconsider ideas like seniority based salaries? I am not sure but I see this as a more general concern and only distantly related to the issue of tenure itself.

But the real issue seems to be whether or not the post-tenure world is good for the academy. I would argue that the answer is no. Perhaps I made a very bad decision to go back into academics at this time given the current pressures but I can't help but think that the levels of deprivation seen by junior academics are dysfunctional. Young Female Scientist talks about the sorts of deprivation that junior academics undergo; after a decade of such lowered standard of living why is it seen as being "lazy or dysfunctional" to want job security?

So I think that there are many good arguments for tenure and I think many of the "anti-tenure" arguments are red herrings.

Saturday, March 28, 2009

Academic Positions

Thoreau (whom I just don't read enough) has a great post on the issues with academic positions in bio-medicine. The recent doubling of the NIH budget has made it possible for the number of academics to dramatically increase. This increase led to people having very unrealistic expectations about academic jobs. In was in Physics in the 1990's when there was a contraction in the field -- I think it is fair to say that the future of Bio-Medicine is about to have some of the sam tragic outcomes.

The worst part is that I don't even have a decent alternate plan.

Cross Sectional Drug Effects

Probably the most frustrating thing in the life of a pharmacoepidemiologist is explaining why cross-sectional drug effects are impossible to estimate. People exposed to a drug at baseline have an outcome that is a composite of:

1) True Drug Effect

2) Underlying Disease Condition (indication for the drug)

It is impossible to separate these effects. So you have strange results when you analyze these data sets: such as anti-hypertensive medications often appear to increase blood pressure when you look at cross-sectional data.

This phenomenon makes it impossible to do any causal inference from a cross sectional drug study if the outcome is even remotely related to the indication. Much grief would be saved if we kept this feature of such studies in mind.